NHSP 2017- 2022 (Final draft)
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
Mapping Report - Ireland.
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Pathak et al. (2016), PeerJ, DOI 10.7717/peerj.1738; 1-14
Towards gender - transformative HIV and TB responses
Learning from the Use of Data, Information, and Digital Technologies in the West Africa Ebola Outbreak Response
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...men characteristics corresponding to the needs of end-users.
more
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Report of a mission 20–24 April 2015
Results of the first national survey, 2013–2014
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...guidelines.
The 2016 interim update to the 2015 BHIVA antiretroviral guidelines has been published online to include tenofovir-alafenamide/emtricitabine as a preferred NRTI backbone for first-line therapy. Changes were based on new data and the consensus opinion of the writing committee. All changes to the guideline are highlighted and include updates to the chronic kidney disease and bone disease sections of special populations and some small changes to managing virological failure.
The 2019 interim statement provides updated advice on treatment with two-drug regimens
more
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review